Verapamil Improves the Activity of Bedaquiline against Mycobacterium abscessus In Vitro and in Macrophages.
- American Society for Microbiology
- Publication Type:
- Journal Article
- Antimicrobial agents and chemotherapy, 2019, 63, (9)
- Issue Date:
|Antimicrobial Agents and Chemotherapy-2019-Viljoen-e00705-19.full.pdf||Published version||1.22 MB|
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Due to intrinsic multidrug resistance, pulmonary infections with Mycobacterium abscessus are extremely difficult to treat. Previously, we demonstrated that bedaquiline is highly effective against Mycobacterium abscessus both in vitro and in vivo Here, we report that verapamil improves the efficacy of bedaquiline activity against M. abscessus clinical isolates and low-level resistant strains, both in vitro and in macrophages. Verapamil may have clinical potential as adjunctive therapy provided that sufficiently high doses can be safely achieved.
Please use this identifier to cite or link to this item: